The Controversy of Alzheimer's Drug Research

This chapter explores the contentious findings surrounding the amyloid hypothesis in Alzheimer's research, focusing on the controversial drug aducanumab and its ineffective outcomes. It highlights the challenges in drug approvals and the critical importance of scientific integrity amid allegations of data fabrication.